Alzamend Neuro, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2022 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Alzamend Neuro, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2022 to Q2 2025.
  • Alzamend Neuro, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending July 31, 2025 was 2.11M shares, a 2369% increase year-over-year.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 451K shares, a 508% increase from 2023.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 74.2K shares, a 88.6% decline from 2022.
  • Alzamend Neuro, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 650K shares, a 99.3% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 2.11M +2.02M +2369% May 1, 2025 Jul 31, 2025 10-Q 2025-09-10
Q1 2025 451K +377K +508% Feb 1, 2025 Apr 30, 2025 10-K 2025-07-22
Q4 2024 5.52M +4.81M +682% Nov 1, 2024 Jan 31, 2025 10-Q 2025-03-10
Q3 2024 3.53M +2.88M +438% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-11
Q2 2024 85.3K -571K -87% May 1, 2024 Jul 31, 2024 10-Q 2025-09-10
Q1 2024 74.2K -576K -88.6% Feb 1, 2024 Apr 30, 2024 10-K 2025-07-22
Q4 2023 705K -5.85M -89.2% Nov 1, 2023 Jan 31, 2024 10-Q 2025-03-10
Q3 2023 656K -5.84M -89.9% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-11
Q2 2023 656K -96.8M -99.3% May 1, 2023 Jul 31, 2023 10-Q 2024-09-11
Q1 2023 650K Feb 1, 2023 Apr 30, 2023 10-K 2024-07-30
Q4 2022 6.56M Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-25
Q3 2022 6.5M Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 97.5M May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.